FindTrial
Sign In

Phase 2 Double-blind Study of S-525606 in Patients with Japanese Cedar Pollinosis Using an Pollen Challenge Chamber

Phase 2 Double-blind Study of S-525606 in Patients with Japanese Cedar Pollinosis Using an Pollen Challenge Chamber

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080222876
Enrollment
Unknown
Registered
2015-06-05
Start date
2015-06-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Japanese cedar pollinosis

Interventions

investigational material(s) Generic name etc : S-525606 INN of investigational material : Therapeutic category code : 449 Other antiallergic agents Dosage and Administration for Investigational mater

Sponsors

Shionogi & Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Allergy test-positive patients who experienced symptoms of Japanese cedar pollinosis in the last two years or more.

Exclusion criteria

Exclusion criteria: Patients who potentially have allergic rhinitis, conjunctivitis or asthma caused by any allergens except for Japanese cedar pollen antigens.

Design outcomes

Primary

MeasureTime frame
Efficacy, safety—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026